Faruqi & Faruqi, LLP is reminding investors who purchased SES AI Corporation securities between January 29, 2025, and March 4, 2026, of the June 26, 2026 deadline to seek appointment as lead plaintiff in a federal securities class action lawsuit. The lawsuit alleges that the company issued materially false and misleading statements regarding its business prospects, overstating results from deals with entities that had limited or no operations. Investors are advised that serving as lead plaintiff is not required to participate in any recovery, but the deadline to move for this role is fast approaching.

The complaint alleges that SES AI created an appearance of revenue by purchasing services in exchange for purchases of Molecular Universe and failed to disclose material logistics constraints in the fourth quarter of 2025. These constraints reportedly affected Q4 2025 revenues and confirmed lower than expected 2026 revenue guidance. On March 4, 2026, SES AI reported its fourth quarter and full year 2025 financial results, disclosing that logistics constraints delayed shipments, pushing approximately $1.5 million of expected revenue into the first quarter of 2026. Following this news, the company's stock price fell $0.63 per share, or 36.84%, to close at $1.08 per share on March 5, 2026.

Case Details

Faruqi & Faruqi, LLP joins other firms investigating the matter, including The Gross Law Firm, Bernstein Liebhard LLP, and The Rosen Law Firm. The case, titled Patel v. SES AI Corporation, et al., is Case No. 26-cv-11894.